Small Cell Lung Cancer (SCLC)

Latest News

Investigators are assessing BI 764532 in extensive-stage small cell lung cancer and other neuroendocrine carcinoma as part of the phase 2 DAREON-5 study.
BI 764532 Earns FDA FTD in Large Cell Lung Neuroendocrine Carcinoma

November 29th 2023

Investigators are assessing BI 764532 in extensive-stage small cell lung cancer and other neuroendocrine carcinoma as part of the phase 2 DAREON-5 study.

Findings from the phase 3 SKYSCRAPER-02 trial support outcomes following atezolizumab plus chemotherapy for patients with extensive-stage small cell lung cancer.
Tiragolumab Combo Does Not Improve Outcomes in Untreated ES-SCLC

November 21st 2023

Patients with extensive-stage small cell lung cancer who receive trilaciclib appear to experience lower rates of hematologic adverse effects than those who are not treated with the agent.
Trilaciclib May Reduce Hospitalization and Improve Survival in ES-SCLC

November 3rd 2023

Responses Observed in Second-Line Sacituzumab Govitecan for Extensive-Stage SCLC
Responses Observed in Second-Line Sacituzumab Govitecan for Extensive-Stage SCLC

October 21st 2023

Tarlatamab may represent a new immunotherapeutic approach for patients with small cell lung cancer, according to the investigators of the phase 2 DeLLphi-301 trial.
Tarlatamab Elicits Responses, Tolerability in Extensive-Stage SCLC

October 20th 2023

Video Interviews
Podcasts
In the final part of the small cell lung cancer podcast series, CancerNetwork® and Wade Iams, MD, discuss the future of treating patients with this disease.
In episode 3 of a 4-part small cell lung cancer podcast series, Wade Iams, MD, highlights practical considerations for treating patients with small cell lung cancer, including managing toxicities and the impact of treatment on a patient’s quality of life.
Wade Iams, MD, broke down some of the different treatment options, including lurbinectedin and topotecan, for patients with relapsed/refractory small cell lung cancer in the second episode of a 4-part small cell lung cancer podcast series.
In the first episode of a 4-part series, CancerNetwork® spoke with Wade Iams, MD, about the various first-line treat options that are available for patients with small cell lung cancer.
Latest CME Events & Activities

2023 IASLC North America Conference on Lung Cancer Satellite Symposia

Register Now!

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

View More

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

View More

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

View More

Show Me Your Care Plan™: Monitoring and Managing Patients With EGFR Exon20 Insertion+ NSCLC

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

Community Practice Connections™: 17th Annual New York Lung Cancers Symposium

View More

40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More

Trekking Through the Latest Updates for ROS1-Targeted Therapies

View More

Mapping Out the Role of Emerging Biomarkers and Testing in NSCLC

View More

Navigating the Latest Data on NTRK-Targeted Therapies

View More

21st Annual Winter Lung Cancer Conference®

Register Now!

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse

View More

The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward

View More

Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target

View More

On-Demand Video Updates from the Annual Oncology Meeting

View More

Pathology Implications for CEACAM5 as a Therapeutic Target in Advanced NSCLC

Martin F. Dietrich, MD, PhD; Neil A. Abrahams, MD; Shirley M. Shiller, DO, AP/CP, MGP, FACP

View More

Medical Crossfire®: What Are Effective Strategies for Onco-Nurses to Improve Outcomes in Patients with Small Cell Lung Cancer?

View More

Virtual Show Me the Data™: How HER2, HER3, and TROP2 Targeted Strategies Will Impact Evolving Paradigms in NSCLC

View More

42nd Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Register Now!

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News